In vitro and in vivo evaluation of ranitidine hydrochloride ethyl cellulose floating microparticles

Journal of Microencapsulation

Volumn 25, Issue 5, 2008, Pages 307-314

  Mastiholimath, V S ^a   Dandagi, P M ^a   Gadad, A P ^a   Mathews, Rashmi ^a   Kulkarni, A R ^a  

^a K L E S S COLLEGE OF PHARMACY   (India)

Author keywords

Bioavailability; Ethyl cellulose; Gastroretentive system; Ranitidine; Solvent evaporation technique

Indexed keywords

ALCOHOL; ETHYL CELLULOSE; MICROSPHERE; RANITIDINE; SOLVENT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG ELIMINATION; DRUG FORMULATION; ENCAPSULATION; EVAPORATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SIMULATION; STOMACH JUICE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOCOMPATIBLE MATERIALS; CELLULOSE; DRUG DELIVERY SYSTEMS; ETHANOL; MALE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; RABBITS; RANITIDINE; SOLVENTS; TIME FACTORS;

EID: 47749156468     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652040801973101     Document Type: Article

References (21)

1. Akbuga, J. and Bergisadi, N. (1996) 5-flourouracil-loaded chitosan microspheres: Preparation and release characteristics. J Microencapsulation, 13, pp. 161-168.
2. Arora, S., Ali, J., Ahuja, A., Khar, RK and Baboota, S. (2005) Floating drug delivery systems: A review. AAPS Pharm Sci Tech, 6, pp. 372-390.
3. Aulton, ME (2002) Pharmaceutics: The science of dosage form design., pp. 206-211. Churchill Livingstone, London
4. Baumgastner, S., Kristel, J., Vreer, F., Vodopivec, P. and Zorko, B. (2000) Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm, 195, pp. 125-130.
5. Brahmankar, DM and Jaiswal, SB (1995) Biopharmaceutics and pharmacokinetics: A treatise, pp. 335-371. Vallabh Prakashan, xNew Delhi
6. Chiao, CS and Robinson, JR (1995) Sustained-release drug delivery systems. Remington: The science and practice of industrial pharmacy, pp. 1660-1675. Mack Publication Company, Eastern Pennsylvania
7. Chien, YW (1992) Concepts and system design for rate-controlled drug delivery in novel drug delivery systems, pp. 1-42. Marcel Dekker Inc, New York
8. Honjec, M. (1986) Ranitidine hydrochloride. Analytical profiles of drug substances, 15, pp. 533-561. Academic Press, New York
9. Joseph, NJ, Laxmi, S. and Jayakrishnan, A. (2002) A floating type oral dosage form for Piroxicam based on hollow microspheres: In vitro and in vivo evaluation in rabbits. J Control Rel, 79, pp. 71-79.
10. Khan, GM (2001) Controlled release oral dosage forms: Some recent advances in matrix type drug delivery systems. The Sciences, 1, pp. 350-354.
11. Klausner, EA, Lavy, E., Friedman, M. and Hoffman, A. (2003) Expandable gastroretentive dosage froms. J Control Rel, 24, pp. 143-162.
12. Lee, TW and Robinson, JR (2000) Controlled release drug delivery systems. Remington: The science and practice of pharmacy, 1, pp. 903-928. Lippincott Williams and Wilkinson, Philadelphia
13. Majeti, M. and Kumar, NV (2000) Nano and microparticles as controlled drug delivery devices. J Pharm Pharm Sci, 3, pp. 234-258.
14. Mathiowitz, E. (1999) Encyclopedia of controlled drug delivery, pp. 729-731. John Wiley and Sons Inc, New York
15. Orellana, GI (2005) Expert Opin. Drug Deliv., 2:3, pp. 419-433.
16. Sankar, C. and Mishra, B. (2003) Development and in vitro evaluation of gelatin microspheres of ketorolac tromethamine for intranasal administration. Acta Pharm, 53, pp. 101-110.
17. Singh, BN and Kim, KH (2000) Floating drug delivery systems an approach to oral controlled drug delivery via gastric retention. J Control Rel, 63, pp. 235-259.
18. Soppimath, KS, Kulkarni, AR and Aminabhavi, TM (2001) Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: Preparation and release characteristics. Drug Dev Ind Pharm, 27, pp. 507-515.
19. Thanoo, BC, Sunny, MC and Jayakrishnan, A. (1993) Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on gastric fluid. J Pharm Pharmacol, 45, pp. 21-24.
20. Vijaya, RD, Medlicott, N., Razzak, M. and Tucker, IG (2002) Microencapsulation of FITC-BSA into poly (ε-caprolactone) by a water-in-oil-in-oil solvent evaporation technique. Trends Biomater Artif Organs, 15, pp. 31-36.
21. Wab, H., Robinson, JR and Lee, VH (1987) Design of oral controlled release drug delivery systems. Controlled drug delivery fundamentals and applications, pp. 418-420. Marcel Dekker, New York